Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion type Assertion NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_head.
- NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion description "[a significant association was observed between the MTHFR haplotype (single nucleotide polymorphisms 677 and 1298) and risk of developing therapy-related-MDS/AML in the breast cancer patients group and cyclophosphamide-treated hematological disease group ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_provenance.
- NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion evidence source_evidence_literature NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_provenance.
- NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion SIO_000772 17476281 NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_provenance.
- NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion wasDerivedFrom lhgdn-20090331 NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_provenance.
- NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_assertion wasGeneratedBy ECO_0000203 NP224854.RA9otL2W5BOsjff0pfmqnjAU8d5_NZWh38suRQ9vf2hSo130_provenance.